Exogenous Ganglioside GM3 Attenuates Atherosclerosis via Multi-Organ Modulation of Lipid Metabolism. [PDF]
Zhou J +4 more
europepmc +1 more source
Advances in Clostridial Neurotoxins: Passage of the Intestinal Barrier and Targeting of Specific Neuronal Cells. [PDF]
Popoff MR.
europepmc +1 more source
Anti-GD1b Disorder Presenting as Multiple Mononeuropathies. [PDF]
Eid K, Araoui R, Ismail R, Sawaya R.
europepmc +1 more source
Sideways lipid presentation by the antigen-presenting molecule CD1c. [PDF]
Cao TP +17 more
europepmc +1 more source
Adult Botulism of Unknown Source with Post-Toxin Anti-GQ1b Antibodies: Implications for Molecular Mimicry-A Case Report. [PDF]
Cohen R +18 more
europepmc +1 more source
AAV9 Gene Therapy in Type II GM1 Gangliosidosis - A Phase 1-2 Trial. [PDF]
Lewis CJ +30 more
europepmc +1 more source
Ganglioside GM3 Participates in the Pathological Conditions of Insulin Resistance*
S. Tagami +11 more
semanticscholar +1 more source
GM1 and GD3 Gangliosides Attenuate Diisopropylfluorophosphate-Induced NGF-TrkA and BDNF-TrkB Signaling Dysfunction. [PDF]
Itokazu Y, Beck WD, Terry AV.
europepmc +1 more source
Ganglioside GM2 induces epithelial-mesenchymal transition (EMT) in cancer cells in a MEK/ERK/Egr1-dependent transcriptional program. [PDF]
Khamrui E +7 more
europepmc +1 more source

